(Q42521871)

1 November 2017

Evaluation of oestrogen receptor expression in breast cancer by quantification of mRNA. (English)

1 reference

1 November 2017

1 reference

3

Bednarek AK

1 reference

1 November 2017

6

Kordek R

1 reference

1 November 2017

Potemski P

1

1 reference

1 November 2017

Pluciennik E

series ordinal

2

1 reference

1 November 2017

Kusinska R

series ordinal

4

1 reference

1 November 2017

Kubiak R

series ordinal

5

1 reference

1 November 2017

1 December 2007

1 reference

1 November 2017

1 reference

1 November 2017

51

1 reference

1 November 2017

829-836

1 reference

1 November 2017

6

1 reference

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

1 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Prognostic relevance of basal cytokeratin expression in operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02886.X

10.1111/J.1365-2559.2007.02886.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference